Mr. Speaker, the government is committed to consulting widely with those who have an interest in intellectual property in Canada in the context of trade agreements.
Nothing in these agreements precludes any sort of policy with respect to pharmacare in Canada. Signing the agreement is not the same as ratifying it. On the TPP, we are doing exactly what we promised we would do during the election campaign. We told Canadians that we would take the time to listen to them and to consult widely on this deal. We have begun this process.
A government-wide approach was taken with regard to the consultations and, as I mentioned, over 200 meetings have been held. This agreement is important and Canadians must be consulted on it.
We heard arguments in favour of the TPP and we heard people's concerns about it. We will hold a proper parliamentary debate on the agreement before a decision is made about whether to ratify it.